Extract from the Register of European Patents

EP About this file: EP2424386

EP2424386 - PEA-BASED PROTEIN MIXTURE AND USE THEREOF IN A LIQUID NUTRITIONAL COMPOSITION SUITABLE FOR ENTERAL FEEDING [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  01.06.2021
Database last updated on 11.04.2026
Most recent event   Tooltip04.06.2021Revocation of patentpublished on 07.07.2021  [2021/27]
Applicant(s)For all designated states
N.V. Nutricia
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
[2012/10]
Inventor(s)01 / HOFMAN, Zandrie
Bosrandweg 20
NL-6704 PH Wageningen / NL
02 / VAN ANHOLT, Rogier Daniël
Bosrandweg 20
NL-6704 PH Wageningen / NL
03 / KIERS, Wynette Hermina Agnes
Bosrandweg 20
NL-6704 PH Wageningen / NL
04 / LUDWIG, Thomas
Bosrandweg 20
NL-6704 PH Wageningen / NL
05 / VAN DEN BRAAK, Claudia Catharina Maria
Bosrandweg 20
NL-6704 PH Wageningen / NL
06 / KLEBACH, Marianne
Bosrandweg 20
NL-6704 PH Wageningen / NL
 [2012/10]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2013/28]
Former [2012/10]Pallard, Caroline Chantal Patricia
Nederlandsch Octrooibureau J.W. Frisolaan 13
2517 JS Den Haag / NL
Application number, filing date10718723.927.04.2010
WO2010NL50236
Priority number, dateWO2009NL5022727.04.2009         Original published format: PCT/NL2009/050227
[2012/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010126362
Date:04.11.2010
Language:EN
[2010/44]
Type: A1 Application with search report 
No.:EP2424386
Date:07.03.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 04.11.2010 takes the place of the publication of the European patent application.
[2012/10]
Type: B1 Patent specification 
No.:EP2424386
Date:29.05.2013
Language:EN
[2013/22]
Search report(s)International search report - published on:EP04.11.2010
ClassificationIPC:A23L33/17, A23L33/19, A61K38/16, A61K36/48, A61K38/01
[2016/17]
CPC:
A61K38/16 (EP,US); A23L33/19 (EP,CN,US); A23L33/185 (EP,CN,US);
A23L33/30 (EP,US); A23L33/40 (EP,CN,US); A61K36/48 (EP,CN,US);
A61K38/018 (EP,CN,US); A61K38/168 (EP,CN,US); A61P1/00 (EP);
A61P1/04 (EP); A61P1/06 (EP); A61P1/08 (EP);
A61P3/02 (EP); A23V2002/00 (EP,CN,US) (-)
C-Set:
A23V2002/00, A23V2250/548, A23V2250/54246, A23V2250/54242, A23V2250/5488, A23V2200/30 (EP,US);
A23V2002/00, A23V2250/548, A23V2250/54246, A23V2250/5424, A23V2250/5488, A23V2200/32 (CN)
Former IPC [2012/10]A23L1/305, A23L1/29
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/10]
Extension statesALNot yet paid
BANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:PROTEINMISCHUNG AUF BASIS ERBSEN UND DEREN VERWENDUNG IN EINER FLÜSSIGEN ZUBEREITUNG ZUR ENTERALEN ERNÄHRUNG[2012/48]
English:PEA-BASED PROTEIN MIXTURE AND USE THEREOF IN A LIQUID NUTRITIONAL COMPOSITION SUITABLE FOR ENTERAL FEEDING[2012/10]
French:MELANGE DE PROTEINES A BASE DE POIS ET SON UTILISATION DANS UNE FORMULE LIQUIDE POUR LA NUTRITION ENTERALE[2012/48]
Former [2012/10]PROTEINMISCHUNG AUF ERBSENBASIS UND IHRE VERWENDUNG IN EINER FLÜSSIGEN NÄHRZUSAMMENSETZUNG, DIE SICH FÜR DIE ENTERALE ERNÄHRUNG EIGNET
Former [2012/10]MÉLANGE DE PROTÉINES À BASE DE POIS ET UTILISATION DE CELUI-CI DANS UNE COMPOSITION NUTRITIONNELLE LIQUIDE APPROPRIÉE POUR L'ALIMENTATION ENTÉRALE
Entry into regional phase22.11.2011National basic fee paid 
22.11.2011Designation fee(s) paid 
22.11.2011Examination fee paid 
Examination procedure24.12.2010Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.11.2011Examination requested  [2012/10]
13.11.2012Communication of intention to grant the patent
15.03.2013Fee for grant paid
15.03.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.11.2012
Opposition(s)Opponent(s)01  14.02.2014  21.02.2014  ADMISSIBLE
Abbott Laboratories
100 Abbott Park Rd.
Abbott Park, IL 60064-6004 / US
Opponent's representative
Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
 02  18.02.2014  21.02.2014  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Stasse 1
61352 Bad-Homburg v.d.H. / DE
 03  26.02.2014  14.03.2014  ADMISSIBLE
Société des Produits Nestlé S.A.
Entre-deux-Villes
1800 Vevey / CH
Opponent's representative
Elkington and Fife LLP, et al, et al
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 04  28.02.2014  14.03.2014  ADMISSIBLE
DF3 SAS(FR) / COSUCRA GROUPE WARCOING(BE)
33 Avenue Paul Clodel/1 rue de la Sucrerie
FR-80480 Dury/BE-Be7740 PECQ-WARCOING / FR
Opponent's representative
Gyi, Jeffrey Ivan
De Clercq & Partners
Edgard Gevaertdreef 10 a
9830 Sint-Martens-Latem / BE
 [N/P]
Former [2019/34]
Opponent(s)01  14.02.2014  21.02.2014  ADMISSIBLE
Abbott Laboratories
100 Abbott Park Rd.
Abbott Park, IL 60064-6004 / US
Opponent's representative
Boult Wade Tennant LLP
5th Floor, Salisbury Square House
8, Salisbury Square
London EC4Y 8AP / GB
 02  18.02.2014  21.02.2014  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Stasse 1
61352 Bad-Homburg v.d.H. / DE
 03  26.02.2014  14.03.2014  ADMISSIBLE
Société des Produits Nestlé S.A.
Entre-deux-Villes
1800 Vevey / CH
Opponent's representative
Elkington and Fife LLP, et al, et al
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 04  28.02.2014  14.03.2014  ADMISSIBLE
DF3 SAS(FR) / COSUCRA GROUPE WARCOING(BE)
33 Avenue Paul Clodel/1 rue de la Sucrerie
FR-80480 Dury/BE-Be7740 PECQ-WARCOING / FR
Opponent's representative
Gyi, Jeffrey Ivan
De Clercq & Partners
Edgard Gevaertdreef 10 a
9830 Sint-Martens-Latem / BE
Former [2018/51]
Opponent(s)01  14.02.2014  21.02.2014  ADMISSIBLE
Abbott Laboratories
100 Abbott Park Rd.
Abbott Park, IL 60064-6004 / US
Opponent's representative
Boult Wade Tennant LLP
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
 02  18.02.2014  21.02.2014  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Stasse 1
61352 Bad-Homburg v.d.H. / DE
 03  26.02.2014  14.03.2014  ADMISSIBLE
Nestec S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Elkington & Fife LLP, et al, et al
Prospect House
8 Pembroke Road
Sevenoaks
Kent TN13 1XR / GB
 04  28.02.2014  14.03.2014  ADMISSIBLE
DF3 SAS(FR) / COSUCRA GROUPE WARCOING(BE)
33 Avenue Paul Clodel/1 rue de la Sucrerie
FR-80480 Dury/BE-Be7740 PECQ-WARCOING / FR
Opponent's representative
Gyi, Jeffrey Ivan
De Clercq & Partners
Edgard Gevaertdreef 10 a
9830 Sint-Martens-Latem / BE
Former [2014/15]
Opponent(s)01  14.02.2014  21.02.2014  ADMISSIBLE
Abbott Laboratories
100 Abbott Park Rd.
Abbott Park, IL 60064-6004 / US
Opponent's representative
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
 02  18.02.2014  21.02.2014  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Stasse 1
61352 Bad-Homburg v.d.H. / DE
 03  26.02.2014   
Nestec S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Kingsbury, Oliver William, et al, et al
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks
Kent TN13 1XR / GB
 04  28.02.2014    ADMISSIBLE
DF3 SAS(FR) / COSUCRA GROUPE WARCOING(BE)
33 Avenue Paul Clodel/1 rue de la Sucrerie
FR-80480 Dury/BE-Be7740 PECQ-WARCOING / FR
Opponent's representative
Gyi, Jeffrey Ivan
De Clercq & Partners
Edgard Gevaertdreef 10 a
9830 Sint-Martens-Latem / BE
Former [2014/14]
Opponent(s)01  14.02.2014  21.02.2014  ADMISSIBLE
Abbott Laboratories
100 Abbott Park Rd.
Abbott Park, IL 60064-6004 / US
Opponent's representative
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
 02  18.02.2014  21.02.2014  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Stasse 1
61352 Bad-Homburg v.d.H. / DE
08.04.2014Invitation to proprietor to file observations on the notice of opposition
16.10.2014Reply of patent proprietor to notice(s) of opposition
10.03.2016Date of oral proceedings
23.03.2016Despatch of minutes of oral proceedings
02.05.2016Despatch of interlocutory decision in opposition
24.11.2020Legal effect of revocation of patent [2021/27]
03.02.2021Despatch of communication that the patent will be revoked
Appeal following opposition11.07.2016Appeal received No.  T1312/16
12.09.2016Statement of grounds filed
24.11.2020Result of appeal procedure: revocation of the patent
03.02.2021Despatch of the decision of the Board of Appeal
05.07.2016Appeal received No.  T1312/16
12.09.2016Statement of grounds filed
24.11.2020Result of appeal procedure: revocation of the patent
03.02.2021Despatch of the decision of the Board of Appeal
14.06.2016Appeal received No.  T1312/16
12.09.2016Statement of grounds filed
24.11.2020Result of appeal procedure: revocation of the patent
03.02.2021Despatch of the decision of the Board of Appeal
20.05.2016Appeal received No.  T1312/16
25.08.2016Statement of grounds filed
24.11.2020Result of appeal procedure: revocation of the patent
03.02.2021Despatch of the decision of the Board of Appeal
24.11.2020Date of oral proceedings
Fees paidRenewal fee
30.03.2012Renewal fee patent year 03
10.04.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.04.2010
CY29.05.2013
CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
MK29.05.2013
MT29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
IE27.04.2014
LU27.04.2014
[2018/30]
Former [2016/32]HU27.04.2010
CY29.05.2013
CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
MT29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
IE27.04.2014
LU27.04.2014
Former [2016/31]CY29.05.2013
CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
MT29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
IE27.04.2014
LU27.04.2014
Former [2016/29]CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
MT29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
IE27.04.2014
LU27.04.2014
Former [2016/22]CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
MT29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
IE27.04.2014
LU27.04.2014
Former [2016/16]CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
MT29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
IE27.04.2014
LU27.04.2014
Former [2015/21]CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
IE27.04.2014
LU27.04.2014
Former [2015/01]CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
LU27.04.2014
Former [2014/11]CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2014/10]CZ29.05.2013
EE29.05.2013
FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2014/02]FI29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
SI29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/51]FI29.05.2013
HR29.05.2013
LT29.05.2013
SI29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/50]FI29.05.2013
LT29.05.2013
SI29.05.2013
BG29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/49]FI29.05.2013
LT29.05.2013
SI29.05.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/48]LT29.05.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/47]LT29.05.2013
PT30.09.2013
Cited inInternational search[XA] US5547927  (COPE FREDERICK O et al.) [X] 19,20 * column 4, lines 62-64 * * column 12, lines 1-4 * * table 6 * * claims 1,7 *[A] 1-18
 [AD] EP1972346  (KATRY INVERSIONES S L et al.) [AD] 1-20 * paragraphs [0001] - [0003] - [0006] - [0010] * * paragraph [0013] * * table 1 * * paragraph [0019] *
 [A] US2003104033  (LAI CHON-SI et al.) [A] 1-20 * paragraphs [0001] - [0003] - [0010] - [0012] * * paragraphs [0013] - [0016] * * paragraphs [0033] - [0039] * * tables 3,8 *
 [A] US2008031860  (HAGEMAN ROBERT JOHAN JOSEPH et al.) [A] 1-20 * examples 1,3 * * paragraphs [0001] , [0028] , [0030] , [0032] - [0033] - [0061] - [0062] *
 [A] WO2007004883  (NUTRICIA NV et al.) [A] 1-20 * page 15, line 25 - page 16, line 18 * * page 5, lines 13-18 * * page 17, lines 17-33 * * Bar on p.24;; example 9 *
 [A] WO2008046857  (NESTEC SA et al.) [A] 1-20 * paragraphs [0001] - [0003] - [0007] , [0019] , [0023] * * example 1 *
 [A] WO2004047549  (CERESTAR HOLDING BV et al.) [A] 1-20 * page 1, paragraph 1 * * page 3 * * page 4, paragraphs 1-3 * * claims 7,14 *
 [AP] WO2009072884  (NUTRICIA NV et al.) [AP] 1-20 * page 1, lines 14-28 * * page 2, lines 14-32 * * page 5, line 15 - page 6, line 30 * * page 10, line 22 - page 11, line 8 * * page 26, lines 1-19 * * claim 15 *
by applicant  MENESES ET AL., NUTR. HOSP., vol. 23, June 2008 (2008-06-01), pages 3 [A] 1-18
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.